Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families
- PMID: 1846765
- DOI: 10.1093/rheumatology/30.1.10
Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families
Abstract
Familial predisposition to chondrocalcinosis (CC) due to calcium pyrophosphate dihydrate (CPPD) crystal deposition is described in five English kindreds. Two families were characterized by premature-onset polyarticular CC with little associated structural arthropathy. In one of these families, recurrent childhood fits were strongly associated with subsequent development of CC. Affected members of the other three families resembled sporadic disease in showing predominantly late-onset, oligoarticular CC with mild arthritis and destructive change in only one case. Knee synovial fluid levels of inorganic pyrophosphate (PPi) and nucleoside triphosphate pyrophosphate (NTPP) did not differ from those of 59 sporadic cases of CC due to CPPD, although PPi and NTPP levels in both groups were higher than in normal knee synovial fluid (P less than 0.0001). Urinary PPi levels were not different from normal controls. Screening for other metabolic abnormality was negative in all cases. This is the first report of familial CC in the UK, and the first to associate this condition with childhood fits. Absence of overt primary abnormality of PPi metabolism suggests that other factors relating to crystal nucleation/growth may be more relevant to predisposition in these cases.
Similar articles
-
Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.J Clin Invest. 1986 May;77(5):1689-93. doi: 10.1172/JCI112487. J Clin Invest. 1986. PMID: 3009553 Free PMC article.
-
Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid.Br J Rheumatol. 1991 Aug;30(4):260-4. doi: 10.1093/rheumatology/30.4.260. Br J Rheumatol. 1991. PMID: 1650620
-
Modulation of chondrocyte production of extracellular inorganic pyrophosphate.Curr Opin Rheumatol. 2004 May;16(3):268-72. doi: 10.1097/00002281-200405000-00017. Curr Opin Rheumatol. 2004. PMID: 15103256 Review.
-
Pyrophosphate arthropathy as a late complication of juvenile chronic arthritis.J Rheumatol. 1984 Apr;11(2):219-21. J Rheumatol. 1984. PMID: 6327981
-
Calcium pyrophosphate dihydrate deposition disease (chondrocalcinosis): a review.Wiad Lek. 2025;78(2):402-409. doi: 10.36740/WLek/200864. Wiad Lek. 2025. PMID: 40125758 Review.
Cited by
-
Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.J Clin Invest. 1994 Aug;94(2):560-7. doi: 10.1172/JCI117370. J Clin Invest. 1994. PMID: 8040311 Free PMC article.
-
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.Am J Hum Genet. 1999 Jan;64(1):136-45. doi: 10.1086/302186. Am J Hum Genet. 1999. PMID: 9915952 Free PMC article.
-
UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte.Ann Rheum Dis. 2003 Jun;62(6):513-8. doi: 10.1136/ard.62.6.513. Ann Rheum Dis. 2003. PMID: 12759286 Free PMC article.
-
Biochemical and genetic analysis of ANK in arthritis and bone disease.Am J Hum Genet. 2006 Dec;79(6):1017-29. doi: 10.1086/509881. Epub 2006 Oct 16. Am J Hum Genet. 2006. PMID: 17186460 Free PMC article.
-
Genetic factors in the pathogenesis of CPPD crystal deposition disease.Curr Rheumatol Rep. 2007 Jun;9(3):231-6. doi: 10.1007/s11926-007-0037-7. Curr Rheumatol Rep. 2007. PMID: 17531177 Review.